Discovery of 2-(α-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS

Christopher J Burns, Michael F. Harte, Xianyong Bu, Emmanuelle Fantino, Marilena Giarrusso, Max Joffe, Margarita Kurek, Fiona Sue Legge, Pasquale Razzino, Stephen Su, Herbert Treutlein, Soo San Wan, Jun Zeng, Andrew F. Wilks

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)


A series of 2-(α-methylbenzylamino) pyrazines have shown to be potent inhibitors of the FMS tyrosine receptor kinase. Details of SAR studies, modeling and synthesis of compounds within this series are reported.

Original languageEnglish
Pages (from-to)1206-1209
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Issue number4
Publication statusPublished - 15 Feb 2009
Externally publishedYes


  • CSF-1
  • CSF-1R
  • FMS
  • Kinase inhibitor
  • M-CSF-1
  • Macrophage

Cite this